Therapy News and Research

RSS

Emergent BioSolutions' anthrax monoclonal antibody IND for Phase I study clears FDA review

Emergent BioSolutions Inc. announced today that its Investigational New Drug (IND) application, to commence a Phase I clinical trial for its anthrax monoclonal antibody therapeutic, has cleared U.S. Food and Drug Administration (FDA) review. The Phase I study will evaluate the safety and pharmacokinetics of the company's fully human monoclonal antibody being developed as a parenteral post-exposure therapy for individuals who have symptoms of anthrax disease. In pre-clinical therapeutic studies, Emergent's monoclonal antibody was found to be effective.

17 May 2010

Celldex Therapeutics commences screening in CDX-1307 Phase 2 study for bladder cancer

Celldex Therapeutics, Inc. today announced that the first patient has been screened in a randomized Phase 2 study of the Company's novel, first-in-class antibody-based vaccine candidate from its Precision Targeted Immunotherapy (PTI) platform. This study will evaluate the CDX-1307 regimen in both neoadjuvant and adjuvant settings in patients with newly diagnosed muscle-invasive bladder cancers that express hCG-beta.

17 May 2010

First Edition: May 17, 2010

Today's headlines highlight stories about efforts to advance the implementation of federal health reforms as well as the sweeping measure's political impact in primary races across the country.

17 May 2010

Roche to commence clinical study of TB-403 in patients with colorectal and ovarian cancer

BioInvent International AB and ThromboGenics NV announce today that their partner Roche will begin an imaging study with the novel anti-cancer antibody TB-403 (RG7334) in patients with metastatic, treatment-refractory, colorectal and ovarian cancer.

17 May 2010

genOway and Griffith University sign research partnership and license for olfactory stem cells technology

genOway, the biotechnology company dedicated to the development of genetically modified animal models, today reports an agreement with the Griffith University (Brisbane, Australia) on a eight-months research partnership with its Eskitis Institute for Cell and Molecular Therapies focusing on autologous olfactory adult stem cells. This research program is coupled with a world wide exclusive license to genOway for the rodent transgenic business.

17 May 2010

Sports physicals keep athletes healthy to play and avoid tragic occurrences, says sports medicine expert

While seemingly invincible teenage athletes at the height of good health and fitness aren't likely candidates for doctor's visits, even the fit need to visit a physician before practice. Sports physicals, often called pre-participation sports examinations, are key to making sure athletes are healthy enough to play and avoiding tragic occurrences, like sudden cardiac death, says a Saint Louis University sports medicine expert.

17 May 2010

New data from MVP trial on ICDs shows health care use burden

Medtronic, Inc. today released new data from the MVP trial that implantable defibrillator patients receiving anti-tachycardia pacing were less likely to have health care utilization after treatment as compared to those receiving shock therapy.

17 May 2010

Early CPAP as effective for preemies as ventilator, with fewer complications: Study

Two findings from an NIH research network study provide new information on how much oxygen very preterm infants should receive starting on the first day of life and the most effective means to deliver it to them.

17 May 2010

Statins may play role in lowering risk of clot-related diseases: Study

Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.

17 May 2010

Anti-abortion groups use health law in efforts to restrict insurance coverage

Abortion opponents fought passage of President Barack Obama's health care overhaul to the bitter end, and now that it's the law, they're using it to limit coverage by private insurers. An obscure part of the law allows states to restrict abortion coverage by private plans operating in new insurance markets.

17 May 2010

3SBio's first-quarter 2010 total net revenues up 40.5%

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the first quarter ended March 31, 2010.

17 May 2010

Researchers identify protein involved in pushing bladder tumors to become invasive

Bladder cancer often becomes aggressive and spreads in patients despite treatment, but now researchers at the Kimmel Cancer Center at Jefferson have identified a protein they believe is involved in pushing tumors to become invasive - and deadly.

15 May 2010

Athersys presents data supporting MultiStem programs

Athersys, Inc. today presented data supporting its MultiStem® programs in cardiovascular disease, neurological disease and immune system modulation, and highlighted advancements in other areas, including progress in its drug development program in the area of obesity.

15 May 2010

Power3 Medical Products files provisional patent applications with USPTO

Power3 Medical Products, Inc. announced today that it has filed two provisional patent applications with the United States Patent and Trademark Office (USPTO) - one on Alzheimer's disease specific differential diagnosis in the clinical setting and the other on important differences in pathophysiology and therapeutic options for the genetically distinct groups of Alzheimer's disease patients.

15 May 2010

Blood flow restriction combined with resistance exercise can increase muscle-mass in older men

For years, researchers have known that resistance exercise training -such as weightlifting, in which muscles work against gravity or another force - can be one of the most effective ways to fight the debilitating muscle loss caused by aging.

15 May 2010

Canadian cancer patients cross the border for second opinion

Two years ago, Beverlee London of Toronto was diagnosed with Stage I lung cancer. London was given the news by her lung specialist in Toronto that she had a malignant tumor on her right lung. She also decided at the time to visit the Barbara Ann Karmanos Cancer Center in Detroit for a second opinion, since she had family living in the area.

15 May 2010

Differential diagnosis and therapy for gait disturbance

One in four people over the age of 70 suffers from gait disturbance. To prevent falls, specific treatment should be given. In the current issue of Deutsches -rzteblatt International, Klaus Jahn and colleagues describe methods of differential diagnosis and therapy (Dtsch Arztebl Int 107[17]: 306-16).

15 May 2010

Low testosterone levels can impact sleep quality

At 30 years old, male testosterone levels drop by one to two percent annually. By age 40, men's quality of sleep begins to diminish. Could there be a link between decreased testosterone and reduced sleep?

15 May 2010

New intervention method reduces self-stigma in mentally-ill patients

A new intervention, the result of a collaboration between researchers from the University of Haifa, City University of New York and Indiana University, was found to reduce the self-stigma and improve the quality of life and self-esteem among persons with serious mental illness.

15 May 2010

Nominations open for 2010 Health Care Stars! Awards

The second annual Health Care Stars! Awards will recognize significant contributions in positively impacting consumers and health care quality. URAC, the nation's leading health care accreditation organization, today announced that nominations are open for the awards which will be presented at the 11th Annual Quality Summit being held October 5-7, 2010 in Chicago, IL.

15 May 2010

Therapy News and Research

Emergent BioSolutions' anthrax monoclonal antibody IND for Phase I study clears FDA review

Celldex Therapeutics commences screening in CDX-1307 Phase 2 study for bladder cancer

First Edition: May 17, 2010

Roche to commence clinical study of TB-403 in patients with colorectal and ovarian cancer

genOway and Griffith University sign research partnership and license for olfactory stem cells technology

Sports physicals keep athletes healthy to play and avoid tragic occurrences, says sports medicine expert

New data from MVP trial on ICDs shows health care use burden

Early CPAP as effective for preemies as ventilator, with fewer complications: Study

Statins may play role in lowering risk of clot-related diseases: Study

Anti-abortion groups use health law in efforts to restrict insurance coverage

3SBio's first-quarter 2010 total net revenues up 40.5%

Researchers identify protein involved in pushing bladder tumors to become invasive

Athersys presents data supporting MultiStem programs

Power3 Medical Products files provisional patent applications with USPTO

Blood flow restriction combined with resistance exercise can increase muscle-mass in older men

Canadian cancer patients cross the border for second opinion

Differential diagnosis and therapy for gait disturbance

Low testosterone levels can impact sleep quality

New intervention method reduces self-stigma in mentally-ill patients

Nominations open for 2010 Health Care Stars! Awards

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News